Rezultati pretrage - Marianna Silletta

  • Prikaz rezultata 1 – 13 od 13
Detaljiziraj rezultate
  1. 1
    New frontiers in the medical management of gastrointestinal stromal tumours

    New frontiers in the medical management of gastrointestinal stromal tumours od Alessandro Mazzocca, Andrea Napolitano, Marianna Silletta, Mariella Spalato Ceruso, Daniele Santini, Giuseppe Tonini, Bruno Vincenzi

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Immunotherapy in Hepatocellular Carcinoma

    Immunotherapy in Hepatocellular Carcinoma od Claudia Angela Maria Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Recent Advances in Desmoid Tumor Therapy

    Recent Advances in Desmoid Tumor Therapy od Andrea Napolitano, Alessandro Mazzocca, Mariella Spalato Ceruso, Alessandro Minelli, Francesca Baldo, Giuseppe Badalamenti, Marianna Silletta, Daniele Santini, Giuseppe Tonini, Lorena Incorvaia, Bruno Vincenzi

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    Early Magnesium Reduction in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan as Predictive Factor of Efficacy and Outcome

    Early Magnesium Reduction in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan as Predictive Factor of Efficacy and Outcome od Bruno Vincenzi, Daniele Santini, Sara Galluzzo, Antonio Russo, Fabio Fulfaro, Marianna Silletta, Fabrizio Battistoni, Laura Rocci, Bruno Beomonte Zobel, Vincenzo Adamo, Giordano Dicuonzo, Giuseppe Tonini

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-B... od Bruno Vincenzi, Massimo Di Maïo, Marianna Silletta, Loretta D’Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone, Giuseppe Tonini

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  6. 6
    Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

    Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials od Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Charalampos‐Vlasios Stikas, Alessandra Gennari, Bruno Vincenzi, Mark R. Openshaw, Marianna Silletta, Matthias Pinter, Alessio Cortellini, Lorenza Scotti, Antonio D’Alessio, David J. Pinato

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib od Francesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, Giulia Bertolini, Giuseppe Cabibbo, Krisida Cerma, Caterina Vivaldi, Luca Faloppi, Mario Domenico Rizzato, Fabio Piscaglia, Ciro Celsa, Lorenzo Fornaro, Giorgia Marisi, Fabio Conti, Nicola Silvestris, Marianna Silletta, Sara Lonardi, Alessandro Granito, Caterina Stornello, Valentina Massa, Giorgio Astara, Sabina Delcuratolo, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy

    Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy od Valentina Burgio, Massimo Iavarone, G.G. Di Costanzo, Fabio Marra, Sara Lonardi, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Ciro Celsa, Francesco Giuseppe Foschi, Marianna Silletta, Daniela Caterina Amoruso, Margherita Rimini, Mariangela Bruccoleri, Raffaella Tortora, Claudia Campani, Caterina Soldà, Massimo Viola, A. Forgione, Fabio Conti, Francesca Salani, Silvia Catanese, Carmelo Marco Giacchetto, Claudia Angela Maria Fulgenzi, Carmine Coppola, Pietro Lampertico, Antonio Pellino, Gabriele Rancatore, Giuseppe Cabibbo, Francesca Ratti, Federica Pedica, Angelo Della Corte, Massimo Colombo, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei‐Gardini

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study

    Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study od Bruno Vincenzi, Andrea Napolitano, Marta Fiocco, Olivier Mir, Piotr Rutkowski, Jean‐Yves Blay, Peter Reichardt, Heikki Joensuu, Elena Fumagalli, Spyridon Gennatas, Nadia Hindi, Margherita Nannini, Mariella Spalato Ceruso, Antoîne Italiano, Giovanni Grignani, Antonella Brunello, Silvia Gasperoni, Tommaso De Pas, Giuseppe Badalamenti, Maria A. Pantaleo, Winan J. van Houdt, Nikki S. IJzerman, Neeltje Steeghs, Hans Gelderblom, Ingrid M.E. Desar, Johanna Falkenhorst, Marianna Silletta, Marta Sbaraglia, Giuseppe Tonini, Javier Martín‐Broto, Peter Hohenberger, Axel Le Cesne, Robin L. Jones, Angelo Paolo Dei Tos, Alessandro Gronchi, Sebastian Bauer, Paolo G. Casali

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

    The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma od Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Özbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi‐Hsiang Huang, Dominik Bettinger, Yehia I. Abugabal, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco Mauri, Alessio Cortellini, Rohini Sharma, Antonio D’Alessio, Celina Ang, David J. Pinato

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

    Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib od Margherita Rimini, Masatoshi Kudo, Toshifumi Tada, S. Shigeo, Wonseok Kang, Goki Suda, André Jefremow, Valentina Burgio, Massimo Iavarone, Raffaella Tortora, Fabio Marra, Sara Lonardi, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Takashi Kumada, Hideki Iwamoto, Tomoko Aoki, Myung Ji Goh, Naoya Sakamoto, Jürgen Siebler, Atsushi Hiraoka, Takashi Niizeki, Kazuomi Ueshima, Takuya Sho, Masanori Atsukawa, Masashi Hirooka, Kunihiro Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Naohiko Shimada, Hiroshi Shibata, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Hideko Ohama, Kazuhito Kawata, Joji Tani, Shinichiro Nakamura, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Takaaki Tanaka, Norio Itokawa, Tomomi Okubo, T. Arai, Michitaka Imai, Kouji Joko, Yuma Koizumi, Yoichi Hiasa, Alessandro Cucchetti, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei‐Gardini

    Izdano 2021
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

    Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis od Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima, Valentina Burgio, S. Shigeo, Toshifumi Tada, Goki Suda, Chi‐Hyeon Yoo, Jaekyung Cheon, David J. Pinato, Sara Lonardi, Mario Scartozzi, Massimo Iavarone, G.G. Di Costanzo, Fabio Marra, Caterina Soldà, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Tiziana Pressiani, Naoshi Nishida, Hideki Iwamoto, Naoya Sakamoto, Baek‐Yeol Ryoo, Hong Jae Chon, F. Claudia, Takashi Niizeki, Takuya Sho, Beodeul Kang, Antonio D’Alessio, Takashi Kumada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiro Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, T. Nishimur, Takeshi Hatanaka, Satoru Kakizaki, Naohiko Shimada, Kazuhito Kawata, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, T. Arai, Michitaka Imai, Atsushi Naganuma, Yuichiro Koizumi, Shinichiro Nakamura, Kouji Joko, Hiroko Iijima, Yoichi Hiasa, Federica Pedica, Francesco De Cobelli, Francesca Ratti, Luca Aldrighetti, Masatoshi Kudo, Stefano Cascinu, Andrea Casadei‐Gardini

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

    Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients od Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Takashi Niizeki, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Bernardo Stefanini, Atsushi Hiraoka, Takuya Sho, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Claudia Campani, Elisabeth Amadeo, Federico Rossari, Valentina Burgio, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: